Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-20-014242
Filing Date
2020-10-02
Accepted
2020-10-02 20:32:56
Documents
1
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_160168515859266.html 4  
1 FORM 4 wf-form4_160168515859266.xml 4 4902
  Complete submission text file 0001628280-20-014242.txt   6225
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

EIN.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7000 SHORELINE COURT, #371 SOUTH SAN FRANCISCO CA 94080
Business Address
Schilke Tobin (Reporting) CIK: 0001678984 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 201222041